Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001564590-19-045741
Filing Date
2019-12-11
Accepted
2019-12-11 16:14:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D nbix-sc13d.htm SC 13D 82693
  Complete submission text file 0001564590-19-045741.txt   84228
Mailing Address 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12780 EL CAMINO REAL SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Filed by) CIK: 0000914475 (see all company filings)

EIN.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Subject) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88403 | Film No.: 191279940
SIC: 2834 Pharmaceutical Preparations